Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19
J Eur Acad Dermatol Venereol
.
2021 Feb;35(2):e98-e100.
doi: 10.1111/jdv.16959.
Epub 2020 Oct 21.
Authors
T Shiohara
1
,
Y Mizukawa
1
Affiliation
1
Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
PMID:
32970885
PMCID:
PMC7537195
DOI:
10.1111/jdv.16959
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Drug Hypersensitivity Syndrome* / etiology
Eosinophilia* / chemically induced
Humans
SARS-CoV-2
Severity of Illness Index